Monthly Newsletter

UVP, LLC is revolutionizing non-invasive in-vivo imaging by enabling researchers to visualize and capture multispectral fluorescently labeled cells.

The iBox system features:

• UVP offers high resolution monochrome CCD camera and the new advanced fluorescent in vivo color imaging capabilities for fast multiple fluorophore detection and analysis.
• High resolution and low light sensitivity allows detection of fluorescent markers deep within the animal
• Wide spectral range emission filters for visible, IR, UV to meet all excitation requirements
• Easy to use software to automate research with templates for consistent, reproducible results
• Real time, non-invasive imaging capabilities speed up basic and preclinical research studies in tumors, oncology, heart and metabolic diseases

"The importance of optical molecular (in vivo) imaging is growing as an invaluable tool for medical, clinical and scientific research," states Alexander Waluszko, VP for Marketing and Sales at UVP. He further states, "UVP's partnership with AntiCancer brings together UVP's global fluorescence and chemiluminescence BioImaging Systems leadership and AntiCancer's world class technology for fluorescent protein imaging. This combined technology enables the study of disease detection and progression, such as cancer. UVP is very pleased to be working with Dr. Hoffman to move forward with the use of fluorescent imaging technology developed by AntiCancer, in hopes of finding medical breakthroughs for the treatment of cancer and other diseases."Anesthesia unit is available to produce a state of immobilization that allows for acquisition of repeatable and reliable data.